Brief: Graft Polymer Says Filing Of US Provisional Patent For Substance Use Disorders Treatment
May 28 (Reuters) - Graft Polymer (UK) Plc GPL.L :
* FILING OF US PROVISIONAL PATENT FOR SUBSTANCE USE
DISORDERS
TREATMENT
Source text for Eikon: ID:nRSb9341Pa
Further company coverage: GPL.L
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Solvonis Therapeutics
See all newsBrief: Solvonis Therapeutics Plans IND Submission For Phase 2B Trial Of SVN-2 In U.S.
Solvonis Therapeutic - Announces Positive Bridging Data Supporting
Solvonis Therapeutic - Notice of Annual General Meeting
RCS - Solvonis Therapeutic - CSO Speaks at National Research Meeting
Solvonis Therapeutic - Final Results